Research ArticleArticle
The Development and Evaluation of Personalized Training in Shared Decision-making Skills for Rheumatologists
Sehrash Mahmood, Johanna M.W. Hazes, Petra Veldt, Piet van Riel, Robert Landewé, Hein Bernelot Moens and Annelieke Pasma
The Journal of Rheumatology April 2019, jrheum.180780; DOI: https://doi.org/10.3899/jrheum.180780
Sehrash Mahmood
From the Amsterdam Rheumatology and Immunology Center, Amsterdam; Erasmus Medical Center, Department of Rheumatology, Rotterdam; Reinier de Graaf Gasthuis, Department of Rheumatology, Delft; Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen; Ziekenhuis Groep Twente, Department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer. S. Mahmood, MSc, Amsterdam Rheumatology and Immunology Center; J.M. Hazes, MD, PhD, Erasmus Medical Center, Department of Rheumatology; P. Veldt, MD, PhD, Reinier de Graaf Gasthuis, Department of Rheumatology; P. van Riel, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare; R. Landewé, MD, PhD, Amsterdam Rheumatology and Immunology Center; H. Bernelot Moens, MD, PhD, Ziekenhuis Groep Twente, Department of Rheumatology; A. Pasma, PhD, Erasmus Medical Center, Department of Rheumatology. Address correspondence to Dr. S. Mahmood, Amsterdam Rheumatology and Immunology Center, De Boelelaan 1117, 1081 HV room 3A56, the Netherlands. E-mail: s.mahmood@vumc.nl. Accepted for publication March 7, 2019.
Johanna M.W. Hazes
From the Amsterdam Rheumatology and Immunology Center, Amsterdam; Erasmus Medical Center, Department of Rheumatology, Rotterdam; Reinier de Graaf Gasthuis, Department of Rheumatology, Delft; Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen; Ziekenhuis Groep Twente, Department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer. S. Mahmood, MSc, Amsterdam Rheumatology and Immunology Center; J.M. Hazes, MD, PhD, Erasmus Medical Center, Department of Rheumatology; P. Veldt, MD, PhD, Reinier de Graaf Gasthuis, Department of Rheumatology; P. van Riel, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare; R. Landewé, MD, PhD, Amsterdam Rheumatology and Immunology Center; H. Bernelot Moens, MD, PhD, Ziekenhuis Groep Twente, Department of Rheumatology; A. Pasma, PhD, Erasmus Medical Center, Department of Rheumatology. Address correspondence to Dr. S. Mahmood, Amsterdam Rheumatology and Immunology Center, De Boelelaan 1117, 1081 HV room 3A56, the Netherlands. E-mail: s.mahmood@vumc.nl. Accepted for publication March 7, 2019.
Petra Veldt
From the Amsterdam Rheumatology and Immunology Center, Amsterdam; Erasmus Medical Center, Department of Rheumatology, Rotterdam; Reinier de Graaf Gasthuis, Department of Rheumatology, Delft; Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen; Ziekenhuis Groep Twente, Department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer. S. Mahmood, MSc, Amsterdam Rheumatology and Immunology Center; J.M. Hazes, MD, PhD, Erasmus Medical Center, Department of Rheumatology; P. Veldt, MD, PhD, Reinier de Graaf Gasthuis, Department of Rheumatology; P. van Riel, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare; R. Landewé, MD, PhD, Amsterdam Rheumatology and Immunology Center; H. Bernelot Moens, MD, PhD, Ziekenhuis Groep Twente, Department of Rheumatology; A. Pasma, PhD, Erasmus Medical Center, Department of Rheumatology. Address correspondence to Dr. S. Mahmood, Amsterdam Rheumatology and Immunology Center, De Boelelaan 1117, 1081 HV room 3A56, the Netherlands. E-mail: s.mahmood@vumc.nl. Accepted for publication March 7, 2019.
Piet van Riel
From the Amsterdam Rheumatology and Immunology Center, Amsterdam; Erasmus Medical Center, Department of Rheumatology, Rotterdam; Reinier de Graaf Gasthuis, Department of Rheumatology, Delft; Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen; Ziekenhuis Groep Twente, Department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer. S. Mahmood, MSc, Amsterdam Rheumatology and Immunology Center; J.M. Hazes, MD, PhD, Erasmus Medical Center, Department of Rheumatology; P. Veldt, MD, PhD, Reinier de Graaf Gasthuis, Department of Rheumatology; P. van Riel, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare; R. Landewé, MD, PhD, Amsterdam Rheumatology and Immunology Center; H. Bernelot Moens, MD, PhD, Ziekenhuis Groep Twente, Department of Rheumatology; A. Pasma, PhD, Erasmus Medical Center, Department of Rheumatology. Address correspondence to Dr. S. Mahmood, Amsterdam Rheumatology and Immunology Center, De Boelelaan 1117, 1081 HV room 3A56, the Netherlands. E-mail: s.mahmood@vumc.nl. Accepted for publication March 7, 2019.
Robert Landewé
From the Amsterdam Rheumatology and Immunology Center, Amsterdam; Erasmus Medical Center, Department of Rheumatology, Rotterdam; Reinier de Graaf Gasthuis, Department of Rheumatology, Delft; Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen; Ziekenhuis Groep Twente, Department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer. S. Mahmood, MSc, Amsterdam Rheumatology and Immunology Center; J.M. Hazes, MD, PhD, Erasmus Medical Center, Department of Rheumatology; P. Veldt, MD, PhD, Reinier de Graaf Gasthuis, Department of Rheumatology; P. van Riel, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare; R. Landewé, MD, PhD, Amsterdam Rheumatology and Immunology Center; H. Bernelot Moens, MD, PhD, Ziekenhuis Groep Twente, Department of Rheumatology; A. Pasma, PhD, Erasmus Medical Center, Department of Rheumatology. Address correspondence to Dr. S. Mahmood, Amsterdam Rheumatology and Immunology Center, De Boelelaan 1117, 1081 HV room 3A56, the Netherlands. E-mail: s.mahmood@vumc.nl. Accepted for publication March 7, 2019.
Hein Bernelot Moens
From the Amsterdam Rheumatology and Immunology Center, Amsterdam; Erasmus Medical Center, Department of Rheumatology, Rotterdam; Reinier de Graaf Gasthuis, Department of Rheumatology, Delft; Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen; Ziekenhuis Groep Twente, Department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer. S. Mahmood, MSc, Amsterdam Rheumatology and Immunology Center; J.M. Hazes, MD, PhD, Erasmus Medical Center, Department of Rheumatology; P. Veldt, MD, PhD, Reinier de Graaf Gasthuis, Department of Rheumatology; P. van Riel, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare; R. Landewé, MD, PhD, Amsterdam Rheumatology and Immunology Center; H. Bernelot Moens, MD, PhD, Ziekenhuis Groep Twente, Department of Rheumatology; A. Pasma, PhD, Erasmus Medical Center, Department of Rheumatology. Address correspondence to Dr. S. Mahmood, Amsterdam Rheumatology and Immunology Center, De Boelelaan 1117, 1081 HV room 3A56, the Netherlands. E-mail: s.mahmood@vumc.nl. Accepted for publication March 7, 2019.
Annelieke Pasma
From the Amsterdam Rheumatology and Immunology Center, Amsterdam; Erasmus Medical Center, Department of Rheumatology, Rotterdam; Reinier de Graaf Gasthuis, Department of Rheumatology, Delft; Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen; Ziekenhuis Groep Twente, Department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer. S. Mahmood, MSc, Amsterdam Rheumatology and Immunology Center; J.M. Hazes, MD, PhD, Erasmus Medical Center, Department of Rheumatology; P. Veldt, MD, PhD, Reinier de Graaf Gasthuis, Department of Rheumatology; P. van Riel, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare; R. Landewé, MD, PhD, Amsterdam Rheumatology and Immunology Center; H. Bernelot Moens, MD, PhD, Ziekenhuis Groep Twente, Department of Rheumatology; A. Pasma, PhD, Erasmus Medical Center, Department of Rheumatology. Address correspondence to Dr. S. Mahmood, Amsterdam Rheumatology and Immunology Center, De Boelelaan 1117, 1081 HV room 3A56, the Netherlands. E-mail: s.mahmood@vumc.nl. Accepted for publication March 7, 2019.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
The Development and Evaluation of Personalized Training in Shared Decision-making Skills for Rheumatologists
Sehrash Mahmood, Johanna M.W. Hazes, Petra Veldt, Piet van Riel, Robert Landewé, Hein Bernelot Moens, Annelieke Pasma
The Journal of Rheumatology Apr 2019, jrheum.180780; DOI: 10.3899/jrheum.180780
The Development and Evaluation of Personalized Training in Shared Decision-making Skills for Rheumatologists
Sehrash Mahmood, Johanna M.W. Hazes, Petra Veldt, Piet van Riel, Robert Landewé, Hein Bernelot Moens, Annelieke Pasma
The Journal of Rheumatology Apr 2019, jrheum.180780; DOI: 10.3899/jrheum.180780